News

Cheetah Net Supply Chain's Third Quarter Review and Insights

Cheetah Net Supply Chain's Third Quarter Review and Insights

Cheetah Net Supply Chain Service Inc. Announces Q3 2025 Results

Cheetah Net Supply Chain Service Inc. (NASDAQ: CTNT), a key player in warehousing and logistics, has shared its financial results for the third quarter of 2025. With the company navigating through a challenging landscape, let’s explore the details surrounding its latest performance.

Financial Highlights from Q3 2025

For the period ending September 30, 2025, Cheetah reported a revenue of $361,935 within its logistics and warehousing segment. However, the operating loss stood at $1,564,479, which incorporates an impairment loss of $731,307 on intangible assets and goodwill. While the company experienced interest income of $236,927, the resulting net loss was $1,314,650—marking a decline of 27.6% compared to the same quarter last year.

CEO's Insights on Current Challenges

Tony Liu, the Chairman and CEO of Cheetah, has made comments regarding ongoing challenges. He noted that tariff turbulence impacting cross-border logistics has posed significant obstacles, exacerbated by diminishing consumer confidence. Despite seeing initial signs of market stabilization in Q2, the recovery of logistics demand has been slower than anticipated. Consequently, Liu mentioned the expectation for revenues in logistics to remain subdued for the remainder of the year.

Operational Adjustments and Future Projections

In light of these ongoing challenges, the management has actively sought to expand its labor and logistics services. Additionally, by optimizing capital from previous public offerings, the company has aimed to sustain steady interest income. Cost control and operational efficiency initiatives are being prioritized, especially as market conditions remain unpredictable.

Cheetah's revenue from Edward Transit Express Group Inc. (acquired in February 2024) contributed $41,935, a decrease of 31.5% year-on-year. This downturn is attributed largely to reduced customer demand stemming from the trade disputes between the United States and China. Shipment volume has failed to rebound to previous levels, primarily due to ongoing uncertainties regarding trade policies.

Looking Forward: Strategies for Growth

The company aims to enhance its operational efficiencies and expand the market presence of its recently acquired businesses in California. With a keen focus on optimizing its resources and strengthening customer relationships, Cheetah anticipates a gradual recovery in performance.

Key Financial Metrics

Cheetah reported operational costs around $317,757 which mainly reflect the labor and logistical expenses for TWEW and costs associated with ocean freight for Edward. Despite the gloom in overall performance, general administration expenses have seen a notable drop of 27.3%, reducing to $801,263. This reduction hints at better management of operational costs and is expected to foster future profitability.

Cash Flow and Liquidity Position

As of September 30, 2025, Cheetah’s total current assets were $9.7 million, with only $0.2 million in cash. Current liabilities related to ongoing operations amounted to about $1.3 million. Through continuous monitoring of liquidity and judicious cash management, the company believes it can sustain operations for at least the next 12 months.

Evaluating the Overall Performance

Despite facing significant barriers, Cheetah’s strategic focus on operational efficiency and market expansion reflects a proactive management ethos. Moving forward, the commitment to closely monitor evolving market dynamics will be critical in navigating both the challenges and opportunities ahead.

Frequently Asked Questions

What were the key financial highlights for Cheetah in Q3 2025?

In Q3 2025, Cheetah reported revenues of $361,935 and a net loss of $1,314,650. The operating loss was recorded at $1,564,479 due to ongoing challenges in the logistics sector.

What challenges is Cheetah facing currently?

Cheetah is navigating difficulties arising from ongoing tariff issues and trade disputes which have significantly affected customer demand and shipment volumes.

How is Cheetah managing its costs?

The company has implemented cost control measures resulting in a 27.3% reduction in general and administrative expenses, aimed at improving operational efficiencies.

What is the outlook for Cheetah in the coming months?

Cheetah anticipates a turbulent yet gradual recovery, maintaining a focus on optimizing operations and customer engagement amidst uncertain market conditions.

How does Cheetah plan to sustain its operations?

The company plans to enhance liquidity through efficient cash management, potential debt financing, and may seek equity financing if necessary to support its growth strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 22

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 14

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
Effective Youth Hockey Skills: Mastering the Basics

Updated Category News Views 35

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Continue Reading
Parents Nationwide Rally for Youth Online Safety Imperative

Updated Category News Views 35

Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
DCK Reveals Versatile Battery-Powered Garden Tools in 2026

Updated Category News Views 65

Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 0

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 143

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 0

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 40

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH

Updated Category News Views 379

Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...

Continue Reading
Solidion Tech Hits Pause on S-1 Amid Market Forces

Updated Category News Views 15

Solidion's Strategic Withdrawal: Timing or Tactical Move? Solidion Technology, for all intents and purposes, just took a step back. Now, before we wave our hands in panic, let's stew over why the withdrawal of their S-1 registration might actually be more of a tactical retreat than a sign of sinking ship. They're pulling the plug on this specific filing—not because...

Continue Reading
Exploring the Future of the Couriers Market and AI's Role

Updated Category News Views 461

The Promising Growth of the Global Couriers Market The couriers market is on the brink of transformation, with expected growth of USD 115.9 billion from 2024 to 2028. This remarkable expansion is being driven primarily by advancements in technology and the integration of artificial intelligence (AI) in various logistics processes. During this period, the market is...

Continue Reading
Survey Reveals Growing Advisor Interest in Private Market Allocations

Updated Category News Views 213

Insights Into Private Market Allocations by Advisors A recent survey highlights a transformative trend among investment advisors regarding their allocation strategies. According to the findings by Hamilton Lane, nearly one-third of advisors are aiming to allocate 20% or more of their clients' portfolios to private markets in the near future. This shows a significant...

Continue Reading
Zack Kass: Driving AI Innovation at International Talent Conference

Updated Category News Views 165

Zack Kass: A Visionary Leader in AI Zack Kass, a prominent AI strategist and executive business advisor, is set to be the keynote speaker at the 2026 International Conference & Exposition organized by the Association for Talent Development. This global event, at the Los Angeles Convention Center, is expected to attract thousands of attendees aiming to explore the latest...

Continue Reading